Trial
NCT04645966
A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Pfizer
Collaborators
—
Condition
Meningococcal Vaccine
Intervention
MenABCWY
Why stopped
The Sponsor decided to discontinue the study based on Sponsor's careful review of available safety data in concert with the recommendation of an independent Data Monitoring Committee.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-25